P.068 Real World Experience With Fingolimod in Canada

Canadian Journal of Neurological Sciences - United Kingdom
doi 10.1017/cjn.2017.152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

MA18.03 How in the Real World Are Lung Cancer Patients Treated? The Ontario, Canada Experience

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis

Patient Related Outcome Measures
2017English

A Swiss Real World Best Practice Experience in Three Different Clinical Settings of the 6 Hour Fingolimod First Dose Observation Procedure

BMC pharmacology & toxicology
MedicinePharmacology
2015English

5psq-075 Safety Profile of Fingolimod in Real World Clinical Practice: A Preliminary Study

2020English

Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting

Journal of Neurology & Neurophysiology
2015English

Real‐World Toxicity Experience With BRAF/MEK Inhibitors in Patients With Erdheim‐Chester Disease

Oncologist
Cancer ResearchMedicineOncology
2019English

Real-World Outcomes in Fingolimod-Treated Patients With Multiple Sclerosis in the Czech Republic: Results From the 12-Month GOLEMS Study

Clinical Drug Investigation
MedicinePharmacology
2016English

Real World Evidence: Experience and Lessons From China

British Medical Journal
Medicine
2018English

The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy